Heat & Weight Drugs: Hydration Alert

As heat waves intensify, individuals taking GLP-1 weight-loss medications face heightened health risks, primarily due to dehydration. Medications such as Ozempic and Mounjaro can alter thirst perception, leading users to drink less fluid, even in extreme temperatures. This reduced thirst, coupled with fluid loss from sweating, significantly increases the danger of dehydration.

Common side effects of GLP-1s, including nausea and vomiting, can be exacerbated by heat, further contributing to fluid loss. Dizziness and hot flushes, also potential side effects, may worsen in high temperatures. It is critical for users to monitor for signs of dehydration, such as dry mouth, fatigue, and reduced urination.

To manage these risks, experts advise proactive hydration, recommending at least 2 to 3 liters of water daily. Setting regular reminders and carrying water are key strategies. Additionally, avoiding direct sun during peak heat, wearing light clothing, and keeping medications cool are important. Consulting a healthcare provider is recommended for persistent symptoms.